Multiple myeloma (MM) is one of the rare and largely incurable malignant diseases of plasma cells. It accounts for 10% of hematological malignancies. According to epidemiological studies, MM was found in 3% of patients with the age of greater than 50 years old and progresses to myeloma or related disorders at a rate of 1% per year. Moreover, the diagnosis of this disease is a major concern as it poses a significant challenge in its management.
Therefore, the advancement of therapy is important in the upgrading of the overall survival of MM patients. In this video, Dr. Pawan Kumar Singh discusses Multiple Myeloma – the importance of early diagnosis in the management of MM, symptoms of MM, diagnostic criteria (CRAB), and need of vigilance in suspecting MM.
